Abstract

329MO HLX208, a novel BRAF V600E inhibitor, in adult patients with Langerhans cell histiocytosis and/or Erdheim-Chester disease harbouring BRAF V600E mutation

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Unraveling the Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms through Whole Exome Sequencing
Minal Patel ... Benjamin Durham
Blood | VOL. 124
Minal Patel, et. al.Minal Patel ... Benjamin Durham
06 Dec 2014
SUN-278 Isolated Hypothalamic Langerhans Cell Histiocytosis in an Adult Manifesting as Panhypopituitarism
Alexandra Mikhael ... Mario Skugor
Journal of the Endocrine Society | VOL. 4
Alexandra Mikhael, et. al.Alexandra Mikhael ... Mario Skugor
08 May 2020
Major response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutation
Giacomo Fiandrino ... Benoit Busser
Journal of the American Academy of Dermatology | VOL. 71
Giacomo Fiandrino, et. al.Giacomo Fiandrino ... Benoit Busser
13 Aug 2014
Primary Langerhans cell histiocytosis of the lacrimal gland in an adult
S Tyler Pace ... Benjamin B Gelman
Canadian Journal of Ophthalmology/Journal canadien d'ophtalmologie | VOL. 50
S Tyler Pace, et. al.S Tyler Pace ... Benjamin B Gelman
31 May 2015
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3
M.P Goetz ... S.R.D Johnston
Annals of Oncology | VOL. -
M.P Goetz, et. al.M.P Goetz ... S.R.D Johnston
01 May 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: ‘ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe’, by A. Bayle et al.
J García-Foncillas ... A Stenzinger
Annals of Oncology | VOL. -
J García-Foncillas, et. al.J García-Foncillas ... A Stenzinger
01 May 2024
Re: Parker CC, Petersen PM, Cook AD, et al. Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial [NCT00541047]. Ann Oncol. 2024 Apr 5:S0923-7534(24)00105-4
Elio Mazzone ... Francesco Montorsi
Annals of Oncology | VOL. -
Elio Mazzone, et. al.Elio Mazzone ... Francesco Montorsi
01 May 2024
Table of Contents
-
Annals of Oncology | VOL. 35
--
01 May 2024
View more papers